Updates from The Motley Fool

Latest updates on NuVasive from Fool.com.

Stock Performance

NUVA vs. S&P 500 | 2 Year Performance
NUVA 1-Day Stock Chart
NUVA 5-Day Stock Chart
NUVA 1-Month Stock Chart
NUVA 3-Month Stock Chart
NUVA 6-Month Stock Chart
NUVA 1-Year Stock Chart
NUVA 2-Year Stock Chart
NUVA 5-Year Stock Chart
View Interactive NUVA Charts
Sponsored by

Key Data Points

Primary metrics and data points about NuVasive.
Current Price: $52.94
Prev Close: $53.10
Open: $52.75
Bid: $50.66
Ask: $0.00
Day's Range: $52.16 - $53.80
52wk Range: $36.81 - $56.61
Volume: 1,153,138
Avg Vol 717,733
Market Cap: $2.60B
P/E (ttm): 112.98
EPS (ttm): $0.47
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about NuVasive.
CAPS Rating 5 out of 5
232 Outperform
17 Underperform
CAPS All Stars
47 Outperform
3 Underperform

How do you think NuVasive will perform against the market?

You pick for NuVasive is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Greg Lucier, CEO

91% Approve

Based on 8 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for NuVasive.

A medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Healthcare IT